BioCo Hungary Ltd. was sold to Ceres Pharma, aiming to enhance international growth opportunities within the expanding dietary supplement market.
Information on the Target
BioCo Hungary Ltd. has established itself as a key player in the domestic vitamin and dietary supplement market. The company has been led and developed by owners and managers Nikolett Sántáné Urbán and Judit Szép for nearly two decades, maintaining tight control over product development, manufacturing, quality assurance, and sales. In October 2025, BioCo was sold to Ceres Pharma, a pharmaceutical distributor based in Belgium, with Heal Partners acting as the advisory partner on the seller's side.
The owners expressed that their vision centered around building a high-quality product range and a strong Hungarian brand, which ultimately led to the decision to sell the company at this time.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview in Hungary
The vitamin and dietary supplement industry in Hungary has seen consistent growth, driven by an increasing consumer focus on health and wellness. As awareness of preventive healthcare rises, the demand for vitamin and su
Similar Deals
Edwards Lifesciences → JenaValve Technology
2026
Ceres Pharma
invested in
BioCo Magyarország Kft.
in 2025
in a Other deal